Download full-text PDF

Source

Publication Analysis

Top Keywords

intracerebral neurotransmitters
4
neurotransmitters conditioned
4
conditioned reflex
4
reflex performance
4
performance [proceedings]
4
intracerebral
1
conditioned
1
reflex
1
performance
1
[proceedings]
1

Similar Publications

Repeated Amphetamine Exposure Blunted Angiotensin II-Induced Responses Mediated by AT Receptors.

Discov Med

January 2025

Department of Pharmacology "Otto Orsingher", Institute of Experimental Pharmacology of Córdoba (IFEC-CONICET), Faculty of Chemical Sciences, National University of Córdoba, X5000 Córdoba, Argentina.

Background: Angiotensin II, is critical in regulating the sympathetic and neuroendocrine systems through angiotensin II type 1 receptors (AT-R). Angiotensin II intracerebral administration increases water and sodium intake, as well as renal sodium excretion. Previously, our group has shown that AT-R is involved in behavioral and neurochemical sensitization induced by amphetamine.

View Article and Find Full Text PDF

New therapeutic agents developed for treating neurological disorders are often tested successfully on rodents. Testing in an appropriate large animal model where there is longer lifespan and comparable brain size to humans should improve translational success and is frequently expected by regulatory bodies. In this project, we aimed to establish a novel sheep model of Parkinson's disease as a large-brained experimental model for translational research.

View Article and Find Full Text PDF

Background: Esketamine (ESK), a noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, modulates neurotransmitter signaling in the central nervous system. However, the specific mechanisms and therapeutic potential of ESK for intracerebral hemorrhage (ICH) remain unclear. This study aimed to investigate whether ESK promotes nerve repair and improves neurological outcomes in an experimental model of ICH.

View Article and Find Full Text PDF

Introduction: Dexmedetomidine, a highly specific α2 agonist, has been extensively utilized in clinical sedation and surgical anesthesia since its introduction in 2000 due to its excellent sympatholytic, sedative, and analgesic effects. This review aimed to identify new approaches for the treatment of patients with brain disorders by thoroughly describing the mechanism of action of dexmedetomidine and examining its neuroprotective effects from the standpoints of basic and clinical research.

Methods: The PubMed and Web of Science databases were searched using the keywords dexmedetomidine and related brain diseases, although relevant articles from the last decade were included for detailed summarization and analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Depression is a major global health issue linked to neuronal dysfunction and calcium imbalances, and Jujuboside A (JuA) shows promise as a potential antidepressant due to its anti-anxiety and anti-insomnia effects.
  • In a study with rats subjected to a depression model, JuA improved depressive behaviors, boosted neurotransmitter levels, and enhanced synaptic connections while also affecting immature neurons and calcium homeostasis.
  • The antidepressant effects of JuA were linked to increased expression of key signaling proteins and were significantly reduced when Sonic hedgehog (Shh) signaling was inhibited, indicating Shh plays a vital role in JuA's mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!